Featured Research

from universities, journals, and other organizations

Physician scientists less likely to be engaged in biomedical research than in past, study shows

Date:
December 12, 2013
Source:
Federation of American Societies for Experimental Biology
Summary:
A new analysis describes the declining participation of physician scientists in biomedical research.

A new analysis published in The FASEB Journal describes the declining participation of physician scientists in biomedical research.

The article, "NIH research funding and early career physician scientists: continuing challenges in the 21st century," cites several indicators of this decline. Physician scientist awardees of National Institutes of Health (NIH) postdoctoral training and career development awards are at an all-time low, and those who continue to pursue a research track receive their first major research grant at a later age than in the 1980s.

"While increased NIH funding during the late 1990s and early 2000s halted the long-term decline in the number of physicians entering research careers, the current environment of reduced NIH funding has further eroded their participation," stated study co-author, Howard H. Garrison, PhD. "Physician scientists have the unique potential to combine clinical perspectives with scientific insight, and if their participation continues to fall, we may lose opportunities to translate basic science discoveries into health care advances."


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. H. H. Garrison, A. M. Deschamps. NIH research funding and early career physician scientists: continuing challenges in the 21st century. The FASEB Journal, 2013; DOI: 10.1096/fj.13-241687

Cite This Page:

Federation of American Societies for Experimental Biology. "Physician scientists less likely to be engaged in biomedical research than in past, study shows." ScienceDaily. ScienceDaily, 12 December 2013. <www.sciencedaily.com/releases/2013/12/131212100221.htm>.
Federation of American Societies for Experimental Biology. (2013, December 12). Physician scientists less likely to be engaged in biomedical research than in past, study shows. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/12/131212100221.htm
Federation of American Societies for Experimental Biology. "Physician scientists less likely to be engaged in biomedical research than in past, study shows." ScienceDaily. www.sciencedaily.com/releases/2013/12/131212100221.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins